Laura Shawver
Director · 1 filing · Latest: Jun 24, 2026
ARS Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SPRY | Shawver Laura | — | Apr 7, 2025 | Proposed Sale | $12.30 | 50,002 | $615.1K | — | |
SPRY | Shawver Laura | — | Mar 5, 2025 | Proposed Sale | $11.00 | 50,000 | $550.0K | — | |
SPRY | Shawver Laura | — | Feb 3, 2025 | Proposed Sale | $12.31 | 50,000 | $615.6K | — | |
SPRY | Shawver Laura | — | Jan 6, 2025 | Proposed Sale | $11.10 | 50,000 | $555.1K | — | |
SPRY | Shawver Laura | — | Dec 2, 2024 | Proposed Sale | $13.57 | 200,000 | $2.7M | — | Dec 9 5:38 PM 144/A |
SPRY | Shawver Laura | — | Dec 2, 2024 | Proposed Sale | $13.57 | 200,000 | $2.7M | — |